IRLAB Therapeutics AB - Class A

NEW
FRA:6IRA (Sweden)   Class A
€ 0.14 +0.0032 (+2.36%) Aug 13
At Loss
P/B:
3.79
Market Cap:
€ 21.48M ($ 24.85M)
Enterprise V:
€ 19.33M ($ 22.37M)
Volume:
0
Avg Vol (2M):
2.04K
Trade In:

IRLAB Therapeutics AB (FRA:6IRA) Dividend

IRLAB Therapeutics AB (FRA:6IRA) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -15.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:6IRA Dividend

Does IRLAB Therapeutics AB (FRA:6IRA) pay a dividend?

IRLAB Therapeutics AB (FRA:6IRA) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't IRLAB Therapeutics AB pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. IRLAB Therapeutics AB has returned capital to shareholders via buybacks at a rate of -15.6% over the past 3 years.

What are dividend-paying alternatives to IRLAB Therapeutics AB?

For dividend-paying alternatives in IRLAB Therapeutics AB's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.